Top Buy
| Security | Buy | Sell | Buy (1M) ▲ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | 21 | 0 | 4 | 0 | €149.20 | €174.43 | 16.913% |
| Thermo Fisher Scientific Inc. | 26 | 0 | 4 | 0 | €550.70 | €568.09 | 3.158% |
| Select Medical Holdings | 6 | 0 | 4 | 0 | €31.20 | €36.41 | 16.688% |
| Corcept Therapeutics Inc. | 11 | 0 | 4 | 0 | €25.12 | €35.43 | 41.040% |
| CONMED Corp. | 12 | 1 | 4 | 0 | €64.00 | €106.18 | 65.905% |
| Hologic Inc. | 17 | 0 | 4 | 0 | €70.00 | €84.52 | 20.744% |
| Align Technology | 15 | 2 | 4 | 0 | €252.30 | €345.95 | 37.119% |
| Addus Homecare Corp. | 15 | 1 | 4 | 1 | €98.00 | €103.07 | 5.174% |
| HCA Holdings Inc. | 22 | 0 | 5 | 0 | €303.20 | €303.80 | 0.197% |
| Merit Medical Systems | 17 | 0 | 5 | 0 | €72.50 | €86.90 | 19.858% |
| MacroGenics Inc. | 14 | 1 | 5 | 1 | €3.07 | €14.25 | 363.696% |
| Zoetis Inc. A | 23 | 1 | 5 | 0 | €156.94 | €200.06 | 27.474% |
| Regeneron Pharmaceuticals Inc. | 34 | 1 | 5 | 1 | €903.60 | €957.22 | 5.934% |
| Eli Lilly Corp. | 50 | 0 | 5 | 0 | €705.70 | €766.92 | 8.674% |
| Gilead Sciences Inc | 12 | 1 | 5 | 0 | €61.21 | €86.77 | 41.760% |
| TG Therapeutics Inc. | 22 | 4 | 5 | 0 | €15.42 | €28.06 | 81.953% |
| Amgen Inc. | 25 | 0 | 6 | 0 | €287.90 | €297.31 | 3.269% |
| Biogen Inc. | 46 | 1 | 6 | 1 | €205.70 | €294.01 | 42.932% |
| Tenet Healthcare | 28 | 0 | 6 | 0 | €117.00 | €121.69 | 4.011% |
| Stryker Corp. | 23 | 0 | 7 | 0 | €306.90 | €335.03 | 9.165% |
| Intra-Cellular Therapies Inc. | 24 | 0 | 7 | 0 | €60.50 | €79.55 | 31.495% |
| Neurocrine Bioscience | 28 | 0 | 7 | 0 | €126.90 | €140.34 | 10.591% |
| Vertex Pharmaceuticals Inc. | 45 | 2 | 7 | 0 | €392.60 | €406.87 | 3.634% |
| Boston Scientific | 46 | 0 | 10 | 0 | €68.50 | €73.05 | 6.638% |